← All sarcoma trials
Recruiting nowAges 18 Years and up

Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06774729 on ClinicalTrials.gov ↗

Conditions studied

Soft Tissue Sarcoma (STS)Bone Cancer Tumor

Where it's running1 site

1 international site
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Age over 18
* suspect of soft tissue sarcoma with a indication for surgical treatment
* suspect of bone cancer tumor with a indication for surgical treatment
* To give informed consent

Exclusion Criteria:

* simultaneous cancer or history of cancer in the last 5 years
* acute or chronic serious conditions that could
* contraindication to conduct a Contrast-enhanced magnetic resonance imaging (MRI) such as:

  * renal failure without dialysis
  * history of allergy to a paramagnetic contrast agent
  * claustrophobia
  * symptomatic epilepsy or history of epilepsy
  * cardiac pacemaker
  * infusion pump, prosthesis or any implant not compatible with MRI
  * pregnancy

Updated 2025-01-14 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.